文献速递先天性心脏病外科

Fontan失败外科负担演变:STS先天性心脏病手术数据库分析

The Evolving Surgical Burden of Fontan Failure: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database.
PubMed 文献 · Ann Thorac Surg · 2020-08-05

基于STS先天性心脏病手术数据库,纳入2010年1月至2018年6月接受Fontan翻修或心脏移植的1135例患者,分析其基线特征与结局。结果显示移植数量增加而翻修减少,移植组术前风险因素更多、HLHS比例更高,两者手术死亡率和复合主要并发症发生率均较高。

要点

  • Fontan失败外科治疗中移植增加、翻修减少,可能与HLHS分期姑息患者增多有关。
  • 移植患者更年轻、术前风险因素更多、HLHS比例更高。
  • 移植和翻修手术死亡率分别为7.6%和7.1%,复合主要并发症/死亡率分别为35%和22%。

核心结论

  • Fontan失败接受移植或翻修均与高并发症和高死亡率相关。
  • Fontan失败的外科治疗实践已发生变化,可能与HLHS分期姑息患者增多有关。

研究设计与样本

  • 回顾性数据库分析,纳入2010年1月至2018年6月在100个中心接受Fontan翻修(n=598)或心脏移植(n=537)的1135例患者。
  • 评估基线特征与结局,并使用多变量logistic回归识别手术死亡及复合死亡和主要并发症的风险因素。

主要发现

  • 移植数量从2010年34例增至2017年76例,主要因HLHS患者增加(2010年18例至2017年49例);Fontan翻修从2010年75例降至2017年49例。
  • 移植患者较翻修患者更年轻(中位14岁 vs 18岁;P < .001),术前风险因素更多(66% vs 40%;P < .001),HLHS更多(51% vs 15%;P < .001)。
  • 移植的手术死亡率和复合主要并发症与死亡率分别为7.6%和35%;Fontan翻修为7.1%和22%。
  • Fontan翻修的手术死亡多变量风险因素包括年龄较大(OR 1.08/岁;P = .007)、存在术前风险因素(OR 3.33;P = .002)和同期肺动脉重建(OR 2.7;P = .029);移植仅年龄较大(OR 1.06/岁;P = .020)。

临床怎么用

  • 临床决策时需认识到Fontan失败无论选择移植还是翻修,手术死亡和主要并发症风险均较高。
  • 对存在术前风险因素、需同期肺动脉重建的Fontan翻修患者,应加强风险评估与围手术期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fontan failure often requires surgical therapy in the form of Fontan revision or heart transplantation. We sought to characterize national trends in the surgical burden of Fontan failure and identify risk factors for adverse outcomes. METHODS: Fontan patients undergoing Fontan revision or transplantation from January 2010 to June 2018 were included. We evaluated baseline characteristics and outcomes and used multivariable logistic regression to identify risk factors for operative mortality and composite mortality and major morbidity. RESULTS: A total of 1135 patients underwent Fontan revision (n = 598) or transplantation (n = 537) at 100 centers. Transplantations increased from 34 in 2010 to 76 in 2017, largely owing to an increase in patients with hypoplastic left heart syndrome (HLHS) (18 in 2010 to 49 in 2017), while Fontan revision decreased (75 in 2010 to 49 in 2017). Transplantation patients were younger (median 14 years of age vs 18 years of age; P < .001), more often had preoperative risk factors (66% vs 40%; P < .001), and more often had HLHS (51% vs 15%; P < .001). Operative mortality and composite major morbidity and mortality were 7.6% and 35% for transplantation and 7.1% and 22% for Fontan revision, respectively. Multivariable risk factors for mortality included older age (odds ratio [OR], 1.08/y; P = .007), presence of preoperative risk factors (OR, 3.33; P = .002), and concomitant pulmonary artery reconstruction (OR, 2.7; P = .029) for Fontan revision but only older age (OR, 1.06/y; P = .020) for transplantation. CONCLUSIONS: Both transplantation and Fontan revision are associated with high morbidity and mortality. There has been evolution of practices in surgical therapy for Fontan failure, perhaps related to rising prevalence of HLHS staged palliation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Serfas JD, Thibault D, Andersen ND, et al. The Evolving Surgical Burden of Fontan Failure: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database. Ann Thorac Surg. 2020. PMID: 32763267. doi:10.1016/j.athoracsur.2020.05.174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。